Integra Therapeutics is now one of the Catalonia Exponential Leaders, an initiative promoted by ACCIÓ (Government of Catalonia) to identify and raise awareness of business projects that can adapt, transform and have a global impact on the most significant economic and social areas for the future.
The distinction has announced today at the 2022 Exponential Day, the fourth edition of this benchmark event in disruption in Catalonia that brought together over 400 experts in innovation and digitalisation, entrepreneurs and executives at CosmoCaixa in Barcelona.
The institutional welcome has given by the Secretary of Business and Competitiveness Albert Castellanos and the Director General for Innovation and Entrepreneurship Lluís Juncà. Castellanos and Juncà described the Catalonia Exponential Leaders as “the most rebellious companies of the moment, an example of the path that can be followed to develop new business models.”
From the metaverse, Dr Avencia Sánchez-Mejías, co-founder and CEO of Integra Therapeutics, explained the path the company has taken to develop its business model through technology transferred from the Pompeu Fabra University Translational Synthetic Biology Laboratory, led by Dr Marc Güell since he returned to Barcelona from Boston in 2017. Integra Therapeutics is developing a next-generation gene writing platform to make advanced therapies safer and more effective so they can reach patients with unmet medical needs as quickly as possible.
In addition to Integra Therapeutics, the other companies recognised were Able Human Motion, AllRead Machine Learning, BMAT, Flax & Kale, Fregata Space, GPA Innova, Innovamat, Kave Home and Uriach.